_edited_edited.png)
Could a Cancer Pathology Review Change Your Diagnosis or Treatment?
Questions you should ask before making an important treatment decision
A cancer diagnosis can bring many decisions in a short time. You may receive pathology and imaging reports and be asked to consider surgery, chemotherapy, radiotherapy, immunotherapy, or another treatment.
Many of these decisions begin with one essential document: your pathology report.
Most pathology diagnoses are clear and reliable. However, when a cancer is rare, complex, uncertain, or does not fit the overall clinical picture, another expert review may provide valuable clarification.
This does not necessarily mean that the original diagnosis was wrong. In many cases, a second review confirms the diagnosis and provides greater confidence before treatment begins.
What Is a Pathology Review?
After the tissue is removed during a biopsy or operation, it is examined by a pathologist—a doctor specially trained to diagnose disease by studying cells and tissues.
The pathology report may describe:
The cancer type and subtype
Tumor grade
Surgical margins
Lymph-node involvement
Immunohistochemistry findings
Treatment-relevant biomarkers
Molecular or genetic alterations
A pathology review means that another qualified pathologist examines the original findings and, when available, the slides or tissue material.
The reviewing pathologist may confirm the diagnosis, clarify the tumor type, reassess the grade or biomarkers, recommend additional testing, or occasionally provide a different interpretation.
Confirmation is also an important result. This can give the patient and treating team greater confidence before proceeding with treatment.
When Should You Consider a Cancer Pathology Review?
Not everyone with cancer needs another pathology opinion. A specialist review may be particularly helpful in the following situations:
The cancer is rare or difficult to classify
Some uncommon tumors can be challenging to diagnose. A pathologist who regularly evaluates that specific cancer type may recognize features not commonly encountered in general practice.
This may be relevant in certain sarcomas, lymphomas, neuroendocrine tumors, unusual blood cancers, and other rare malignancies.
The pathology report is uncertain
Terms such as “atypical,” “indeterminate,” “suspicious,” or “cannot exclude” may indicate that the findings are not fully conclusive.
This does not automatically mean that an error has occurred. The tissue sample may be too small or insufficient, and additional testing or another expert review may be needed.
The pathology does not match the clinical picture
Sometimes, the pathology results may not appear consistent with the tumor location, imaging findings, pattern of spread, or response to treatment.
When the different pieces do not fit together, reviewing the pathology alongside the scans and medical history may help clarify the situation.
A major treatment is being considered
Before extensive surgery or other treatment with important long-term consequences, confirming the essential diagnosis may provide reassurance.
However, an additional review should not create an unsafe delay. The treating oncologist should determine whether it is medically appropriate to wait.
The cancer returns or behaves unexpectedly
If cancer returns in an unusual way or does not respond as expected, doctors may reconsider the original diagnosis or tumor biology.
Reviewing the original tissue may be helpful. In some cases, a new biopsy may provide more current information because cancer can change over time and after treatment.
Biomarker results will guide treatment
Modern cancer treatment increasingly depends on biomarkers such as hormone receptors, HER2, PD-L1, mismatch-repair proteins, and specific molecular alterations.
If an important biomarker result is borderline, unexpected, or inconsistent with other findings, confirmation or additional testing may be appropriate.
Can a Pathology Review Change Treatment?
Sometimes—but not always.
Treatment recommendations may change if the review identifies a different cancer type or subtype, revises the tumor grade, clarifies surgical margins, or changes an important biomarker result.
For example, clarification of a biomarker may affect the use of targeted therapy, immunotherapy, or hormone therapy. A revised tumor classification may also point toward a different treatment approach.
In many cases, however, the original diagnosis is confirmed. This remains valuable because it allows major treatment decisions to proceed with greater confidence.
Pathology Review and Oncology Second Opinion
A pathology review and an oncology second opinion are related, but they answer different questions.
A pathology review focuses on:
Tissue diagnosis
Cancer type and subtype
Tumor grade
Surgical margins
Biomarkers and molecular findings
The need for additional tissue testing
An oncology second opinion considers the broader clinical picture, including:
Pathology findings
Imaging results
Cancer stage
Previous treatment
General health
Biomarker and molecular results
The proposed treatment plan
Alternative treatment options
During an oncology review, the oncologist may identify a reason to request a specialist pathology review. Once available, the pathologist’s findings can be incorporated into the overall treatment assessment.
The two services are complementary, but they are not the same.
What Materials May Be Needed?
The reviewing pathologist or institution may request:
The complete pathology report
Glass slides or digital pathology images
Paraffin tissue blocks or unstained slides
Immunohistochemistry reports
Molecular test results
Relevant imaging and clinical information
The original hospital or laboratory may require a signed authorization before releasing these materials. Patients should first confirm what is needed, where it should be sent, and whether the materials will be returned.
Questions You Should Ask
If you are considering a pathology review, ask your medical team:
Is my pathology diagnosis clear and complete?
Is this a rare or difficult-to-classify cancer?
Do the pathology findings match my scans and clinical presentation?
Have all treatment-relevant biomarkers been evaluated?
Could another interpretation change my diagnosis or treatment?
Is it medically safe to wait for the review before starting treatment?
The most relevant questions will depend on the cancer type, the clarity of the original report, and the treatment decision being considered.
How ICON Can Help
ICON provides independent oncology case reviews for patients seeking greater clarity about their cancer diagnosis or proposed treatment plan.
The review considers available pathology reports, imaging findings, cancer stage, previous treatments, biomarkers, molecular results, general health, and current treatment options.
When clarification of the tissue diagnosis could influence treatment decisions, ICON may recommend—and, where appropriate and available, help coordinate—an independent review by a qualified pathologist.
The pathologist is responsible for examining the slides or tissue material, confirming or refining the diagnosis, reviewing relevant biomarkers, and recommending any necessary additional pathology testing.
The pathology findings can then be considered within the broader oncology review to provide clear, evidence-based treatment recommendations.
The ICON oncology review does not replace the direct examination of tissue by a qualified pathologist. The two services have different but complementary roles.
Final Thoughts
Most pathology diagnoses are accurate and reliable. However, another expert review may be valuable when a cancer is rare, uncertain, complex, or inconsistent with other medical findings.
A pathology review may confirm a diagnosis, clarify an important detail, identify the need for additional testing, or occasionally influence treatment.
It is not about rejecting the first medical team. It is about making important treatment decisions with the clearest information available.
Reviewed by: Dr. Omid Modiramani, MD
Medical Oncologist & Hematologist
Founder, ICON – International Cancer Opinion Network
Uncertain About Your Cancer Diagnosis or Treatment Plan?
Get an independent, evidence-based oncology review from ICON.
Secure online review • Personalized recommendations • Available internationally
References
Medical Disclaimer : This article provides general educational information and does not replace personalized medical advice, formal pathology consultation, diagnosis, or treatment recommendations from a qualified healthcare team.
Comments